metyrapone has been researched along with Central Nervous System Origin Vertigo in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kley, HK | 1 |
| Krüskemper, HL | 1 |
| Sakashita, K | 1 |
| Yokomi, Y | 1 |
2 other studies available for metyrapone and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
[Performance and interpretation of a shortened metyrapone test].
Topics: 11-Hydroxycorticosteroids; Acromegaly; Adolescent; Adult; Aged; Circadian Rhythm; Diabetes Mellitus; | 1972 |
[Vertigo caused by SU 4885 (drug used in the hypophyseal function test)].
Topics: Adult; Brain Injuries; Electrooculography; Female; Humans; Male; Metyrapone; Middle Aged; Pituitary | 1971 |